Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 21, 2026
SPCH: Is $15 Within Reach for the 2X SpaceX Leveraged ETF?

SPCH: Is $15 Within Reach for the 2X SpaceX Leveraged ETF?

Key Takeaways

  • SPCH is a leveraged single-stock ETF seeking twice (2X) the daily return of SpaceX (traded as SPCX); it recently traded near $9.87, far below its $28.01 52-week high.
  • A move to $15 would require a gain of roughly 50% and sits within a technical retracement zone between the fund's launch high and its $5.30 low.
  • The bullish case rests on SpaceX's underlying Starlink and launch businesses, supported by analyst price targets averaging near $278 on the underlying stock.
  • The biggest obstacle is structural: daily rebalancing and compounding cause leveraged ETFs to decay and deviate from 2X performance when held beyond a single day.
  • Investors should treat the $5.30 low as the key support level and the $15-to-$16.66 zone as the first major resistance area.

Understanding What SPCH Really Does

Before considering whether the price can climb, it helps to understand what this product does. The Leverage Shares 2X Long SPCX Daily ETF is an exchange-traded fund (ETF) launched in June 2026 that aims to deliver 200% of the daily price performance of Space Exploration Technologies Corp., better known as SpaceX. It achieves this through swap agreements and other derivatives rather than by owning SpaceX shares directly, and it rebalances its exposure every day. The fund carries a 0.75% expense ratio and manages roughly $313 million in assets.

That daily reset is the critical detail. The fund is designed for short-term tactical traders, not buy-and-hold investors, because its returns over periods longer than one day can diverge sharply from a simple 2X multiple of SpaceX's cumulative move. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the industry.

Why $15 Stands Out as a Key Level

SPCH listed shortly after SpaceX's blockbuster June 2026 initial public offering, which raised about $85.7 billion and priced shares at $135 before opening near $150. The leveraged fund quickly spiked to a 52-week high of $28.01, then collapsed as enthusiasm cooled, bottoming around $5.30. It has since recovered to roughly $9.87.

Against that backdrop, $15 is a natural focal point. It represents a psychologically significant round number, sits roughly halfway back toward the fund's all-time high, and aligns with a technical retracement zone between the 38.2% and 50% levels of the decline from $28.01 to $5.30. In other words, it is a price level where sellers who bought higher may look to reduce positions, making it a meaningful resistance level for the next leg of any recovery.

What Could Drive the ETF Toward $15

The path higher runs almost entirely through SpaceX itself. The underlying company operates a commercial launch business and the Starlink satellite-broadband network, and analysts have also begun assigning value to its artificial-intelligence ventures. The average analyst price target for SPCX sits near $278, with Morgan Stanley maintaining a $300 target tied in part to AI initiatives, while Raymond James has published a Street-high $800 objective.

If SpaceX shares mount a sustained rally, the 2X daily structure means SPCH would move roughly twice as much on a day-to-day basis, potentially carrying it back through $15 relatively quickly in a strong uptrend. Continued index-inclusion flows, improving sentiment around Starlink growth, and a repricing of the AI segment are the factors most likely to provide that catalyst.

The Leverage Challenge Working Against It

For all that upside, the product's structure is a double-edged sword. Because SPCH resets its exposure daily, volatility drag can erode value even when the underlying stock ends up unchanged or modestly higher over time. During the fund's sharp drawdown from $28 to $5.30, this effect was on full display: leveraged long products can lose a large share of their value in a choppy market.

There is also a path-dependency issue. A $15 target reached through a slow, choppy grind upward is harder to achieve than the same level reached through a rapid, uninterrupted rally, because daily rebalancing compounds losses on down days. This is why the fund's own disclosures describe it as a short-term tactical tool rather than a long-term investment vehicle.

Key Levels to Watch

On the downside, the $5.30 52-week low remains the critical support level; a decisive break below it would signal renewed selling pressure and invalidate the recovery thesis. On the upside, $15 marks the first major resistance zone, with the $16.66 area and, ultimately, the $28.01 launch high representing progressively more ambitious milestones. For traders, the relevant question is less whether SpaceX can eventually reach higher prices than whether the rally arrives fast enough for the daily-reset structure to capture it.

Monitoring With AI Daily Buy/Sell Signals

Traders following leveraged instruments like SPCH often use automated tools to track changing conditions. In my own process, I rely on Tickeron’s AI Daily Buy/Sell Signals to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on shifting market behavior, technical patterns, and AI-driven analysis. Because leveraged funds can reverse direction quickly, these signals can help traders spot emerging opportunities, monitor existing positions, and identify changing trends more efficiently than manual screening alone.

Final Assessment

A move to $15 is not out of the question for SPCH, but it depends heavily on timing and on a sustained advance in SpaceX shares. The strongest factors supporting the level are SpaceX's underlying business momentum, a Street consensus that sees meaningful upside in SPCX, and the mechanical reality that a strong, fast rally would carry the 2X fund higher rapidly. The primary risks are equally clear: leveraged-ETF decay, extreme volatility, and the possibility that SpaceX shares consolidate sideways long enough for daily rebalancing to erode returns. Investors should monitor SpaceX's price action, the fund's ability to hold above its recent lows, and whether momentum is strong enough to overcome the structural drag built into a daily-reset product.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SPCH

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Industry description

The investment seeks daily leveraged investment results, before fees and expenses, of two times (200%) of the daily percentage change in the price of the common stock of SPCX. The fund is an actively managed ETF. It invests at least 80% of its net assets (plus borrowings for investment purposes) in the Underlying Security and financial instruments with economic characteristics that, in combination, provide 200% daily leveraged exposure to the price of the Underlying Security, on a daily basis, consistent with the fund’s investment objective. The fund is non-diversified.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
United States
Phone
N/A
Web
www.ThemesETFs.com
Interact to see
Advertisement
AMZN stock declined approximately -4% over the past 30 days amid concerns over elevated AI-driven capital expenditures pressuring margins. Over the past quarter, the stock fell around -13%, reflecting post-earnings selloff and broader tech sector volatility. Major drivers include surging AWS demand offset by high capex forecasts of up to $200 billion for 2026, macroeconomic pressures like trade policy risks, and geopolitical tensions impacting sentiment.
Taiwan Semiconductor Manufacturing Company Limited (TSM) ADRs rose 4.68% in the most recent completed session, climbing from a prior close of $316.50 to $331.32. The move comes after a brief two‑day pullback and reflects renewed buying interest as investors refocus on TSMC’s role at the center of the AI chip supply chain.
APA Corporation delivered strong Q4 2025 results, beating EPS estimates with $0.91 adjusted earnings per share and $1.0 billion full-year free cash flow. Stock surged over 45% in recent weeks amid rising oil prices and geopolitical tensions, hitting 52-week highs near $45.66. 2026 capital plan set at $2.1 billion, targeting cost savings run-rate of $450 million and flat U.S. oil production.
I've been watching DVN closely in recent sessions, and it's held up well amid a broader energy sector rally driven by elevated oil prices. The stock has outperformed broader indices, which speaks to investor confidence in its strong positioning in U.S. shale plays, especially the Permian Basin. Volatility remains a factor with macroeconomic pressures and commodity swings, but the company's emphasis on capital discipline and returns to shareholders has encouraged steady buying. Trading volumes have increased, indicating growing interest as DVN manages merger developments and production shifts in this market cycle.
LLY stock declined -13% over the past 30 days amid concerns over obesity drug pricing pressures and competition from NVO. Over the past quarter, the stock fell around -17%, despite strong Q4 2025 earnings driven by Mounjaro and Zepbound volume growth. Bearish analyst notes on market saturation and potential price wars outweighed positive trial data for next-gen drugs like retatrutide.
I've been keeping a close eye on EOG Resources (EOG), and it's clear the stock has held up well through recent volatility. Year-to-date gains are approaching 38%, which stands out against the broader energy sector. The shares are trading above key moving averages, supported by investor confidence in the company's low-cost production and diversified multi-basin portfolio. Elevated crude oil prices have provided a tailwind, even as macroeconomic pressures have led to occasional dips. With a solid balance sheet and reliable free cash flow, EOG looks well-positioned in this market cycle.
Diamondback Energy (FANG), a leading independent oil and natural gas producer focused on the Permian Basin, has shown impressive resilience lately. In my view, the stock's climb of around 16% over recent weeks stands out, especially as it has traded near its 52-week high while outperforming key energy indices and the broader market. This momentum seems driven by favorable oil price dynamics, positive analyst revisions, and the company's operational efficiency paired with its exposure to rising crude benchmarks. Even with broader market fluctuations, FANG's robust cash flows and recent dividend enhancements continue to draw interest from both momentum traders and long-term investors.
MTDR stock surged +20% over the past 30 days, driven by escalating oil prices amid Iran conflict disruptions and strong Q4 2025 earnings beat. Over the past quarter, shares climbed +53%, fueled by record production, positive 2026 guidance, and analyst price target upgrades.
I've been watching OXY closely, and it's clear the stock has shown robust strength in recent trading sessions. It's advanced amid heightened oil prices driven by global supply concerns, outperforming broader indices. This reflects investor confidence in its Permian Basin dominance and operational resilience. Trading near the upper end of its 52-week range, OXY benefits from elevated crude realizations that enhance margins in its core upstream business. While sector peers have also gained, the company's focus on cost efficiencies and debt reduction positions it favorably in the latest market cycle. Heightened volume underscores sustained interest as macroeconomic pressures test energy equities.
I've been watching Antero Resources (AR) closely through recent trading sessions, where the stock has handled volatility well amid natural gas price swings and broader energy sector shifts. It's trading near the upper end of its 52-week range, with year-to-date gains exceeding +25%. From what I see, this reflects investor confidence in the company's growing Marcellus footprint and its disciplined approach to capital allocation. The upward momentum ties directly to positive analyst revisions and a solid production outlook. Macro factors like LNG export demand and data center growth continue to support sentiment in the natural gas space.
I've been tracking Magnolia Oil & Gas (MGY) closely, and it's clear the stock has put in a strong showing lately. It's trading near the top of its 52-week range, buoyed by positive dynamics in the energy sector. From what I see, investor interest in oil and gas producers like MGY is picking up, thanks to improved production efficiency and a focus on capital discipline. The shares have held up well, with a PE ratio around 18 and a dividend yield close to 2%. Sector-wide support from stronger commodity prices has helped drive this momentum, placing MGY in a solid spot among exploration and production peers. Trading volume reflects this engagement, aligning with the broader uptick in activity.
PR stock surged +18% over the past 30 days, driven by investment-grade credit rating upgrades from S&P and Fitch, analyst price target increases, and rising oil prices. Over the past quarter, shares climbed +55%, fueled by record Q4 2025 production, strong earnings beat, dividend hike, and robust operational efficiencies. Key factors include credit upgrades enhancing financial flexibility, positive analyst sentiment with multiple buy ratings, and favorable sector trends from higher crude oil realizations.
RRC stock rose +11% over the past 30 days, driven by strong Q4 2025 earnings beat, dividend hike, and positive 2026 guidance. Over the past quarter, shares gained +31%, reflecting robust free cash flow generation and operational efficiency in the Appalachian Basin.
From what I see, Exxon Mobil Corporation (XOM) stands out as one of the world's largest integrated energy companies, involved in the exploration, production, refining, and marketing of oil, natural gas, and petrochemicals. Its business model covers the full hydrocarbon value chain, from upstream production to downstream refining and chemicals, which offers diversification against commodity price swings. In the oil and gas industry, Exxon Mobil maintains a leading position thanks to its vast reserves, especially in high-return areas like the Permian Basin in the U.S. and offshore Guyana. The company's strong fundamentals—record production volumes and ongoing cost savings—have supported recent stock strength, as higher oil prices boost upstream earnings and refining profits from wider margins.
I've been watching TMV closely through recent trading sessions, where it's handled heightened volatility linked to swings in long-term Treasury yields. This ETF delivers -3x the inverse daily performance of 20+ year U.S. Treasuries, and it's held up well amid pressures in the broader fixed income space. From what I see, rising energy costs and macroeconomic uncertainties have driven yields higher, which plays right into TMV's strengths. The fund is trading within its 52-week range, backed by strong liquidity and substantial daily volume—making it suitable for active traders looking to position around rate-sensitive moves. Recent market cycles really underscore TMV's value in tactical strategies tied to bond market shifts.
From what I see, Constellation Energy stands out as the largest producer of carbon-free energy in the U.S., with the nation's biggest nuclear fleet boasting over 21 GW of capacity—that's roughly 10% of U.S. clean energy output. This scale delivers unmatched reliability for baseload power, which is exactly what hyperscalers like Microsoft and Meta need for their 24/7 carbon-free electricity demands to power AI data centers. Post-Calpine acquisition, the company's ~55 GW fleet now spans nuclear, natural gas, and renewables, providing geographic diversity across key markets like PJM and ERCOT.
In my view, Karman Holdings Inc. (KRMN) really stands out in the aerospace and defense sector with its focus on mission-critical subsystems, including payload protection and deployment systems, aerodynamic interstage systems, and propulsion systems. The company serves high-growth markets like hypersonics, strategic missile defense, tactical missiles, and space launch, benefiting from proprietary engineering and manufacturing capabilities that enable rapid development for prime contractors.
As one of the top three global players in the semiconductor memory market, Micron Technology holds about 22% share in DRAM and is building a stronger foothold in NAND flash storage. What stands out to me is the company's leadership in high-bandwidth memory (HBM), which is essential for AI accelerators. By early 2026, Micron has secured around 21% market share here, thanks to its efficient 12-high and 36GB HBM4 stacks that use 30% less power than competitors.
I've been following Viridian Therapeutics ($VRDN) closely as it carves out a strong position in the thyroid eye disease (TED) market—a rare autoimmune disorder that causes orbital inflammation, proptosis, diplopia, and even vision loss in severe cases. The company draws on its antibody discovery and protein engineering expertise to create differentiated IGF-1R inhibitors, building on the validated pathway pioneered by Tepezza (teprotumumab). What stands out to me is how veligrotug diverges from Tepezza's frequent IV infusions: it offers a more convenient 12-week course with robust efficacy demonstrated in Phase 3 trials for both active and chronic TED, which could help it gain market share through better patient tolerability.
I've been following Applied Optoelectronics, Inc. (AAOI) closely as it designs, manufactures, and sells fiber-optic networking products, including optical transceivers, lasers, and components. These serve internet data centers, cable television (CATV), telecom, and fiber-to-the-home (FTTH) markets. What stands out is the company's vertically integrated model—from chip fabrication using proprietary molecular beam epitaxy (MBE) lasers to module assembly—which gives it an edge in rapid innovation and cost control.